- Nachrichtendetail
-
07.05.2024 17:09:51 - dpa-AFX: *FDA ADVISORY COMMITTEE TO REVIEW ELI LILLY'S DONANEMAB FOR EARLY ALZHEIMER'S TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 903,818 | 25.06.24 20:15:10 | +13,708 | +1,54% | 903,500 | 904,260 | 891,770 | 890,110 |
